… transplant rejection, researchers report in a study published Wednesday in Science Translational Medicine …

TOPLINE: In paediatric kidney transplant recipients, high variability in tacrolimus trough blood levels was significantly associated with allograft rejection occurring beyond 12 months post-transplant; however, rapid tacrolimus metabolism was significantly …

… of Medicine (YSM) may allow clinicians to monitor for signs of organ rejection … as a biomarker for heart transplant rejection in animal models, according to … .    This grading helps guide treatment decisions. Treatment for moderate or severe acute …

While immunosuppressive medications are critical to prevent rejection of transplant organs, they also come with plenty of downsides. They can cause harsh side effects, like headaches and tremors, and increase the risk for infection and cancer. But what if …

Scientists tracked how human immune cells attack pig kidneys after transplant—and found a way to fight back using precision therapies in the early rejection phase. Credit: Shutterstock In a breakthrough study, scientists used spatial molecular imaging to …

… a precise readout of heart transplant rejection. Although routine endomyocardial biopsy remains … , according to the authors. Monitoring Treatment Success By escalating immunosuppression, the … , MD, of Yale School of Medicine. According to the researchers, a …

… es­sen­tial an­ti-re­jec­tion drug for or­gan trans­plant … de­scribed the re­cur­ring drug short­age as a … fail­ure, hos­pi­tal­i­sa­tion, and or­gan re­jec­tion—some re­sort­ing to ex­pen­sive … force to mon­i­tor trans­plant drug sup­ply. In re­sponse, …

… drug that's already available – and used to prevent organ rejection … Yale School of Medicine. He developed and performed … #39; she suggests. Another drug, elinzanetant, targets an additional … 'Focusing on these treatments, along with our increasing awareness …

… assess the risk of transplant rejection, between the two … used to support clinical treatment decisions. The company is … scientific discovery in transplant medicine, and how GraftAssureIQ could … a trusted biomarker of transplant rejection, and iMDx is now …

A new study found a powerful new tool for monitoring liver transplant patients: a simple blood test that detected early signs of organ damage and identified its source. The findings, which could significantly improve transplant outcomes and reduce the need …